Опыт применения и перспективы лечения антиандрогенами лиц с парафилиями (аналитический обзор)

Полный текст:
Читать

Рекомендуемое оформление библиографической ссылки:

Введенский Г.Е., Басинская И.А. Опыт применения и перспективы лечения антиандрогенами лиц с парафилиями (аналитический обзор) // Российский психиатрический журнал. 2013. №3. С. 41-47.

Аннотация

Рассматриваются основные проблемы применения антиандрогенов в лечении парафилий по данным зарубежной и российской литературы, анализируются показания и противопоказания к их назначению, побочные действия и эффективность.

Ключевые слова парафилии; антиандрогены

Литература

1. Басинская И.А. Комплексное лечение лиц совершивших сексуальные правонарушения и оценка их общественной опасности: Автореф. дис. ... канд. мед. наук. - М., 2012. 2. Введенский Г.Е. Опыт применения антиандрогенов в лечении психически больных сексуальных правонарушителей // Тезисы Всерос. науч.-практ. конф. "Современные проблемы социальной и клинической сексологии". 13-15 сентября 2012. - Казань, 2012. - С. 287-288. 3. Возианов А.Ф., Резников А.Г., Клименко И.А. Принципы медикаментозной терапии рака предстательной железы // Пособие для врачей. - К., 2003. - 36 с. 4. Шредер Ф.Х., Вилан П., де Рейке М. и др. Метастатический рак простаты - рандомизированное исследование ципротерона ацетата в сравнении с флутамидом (EORTC 30892, окончательный анализ) // Материалы междунар. науч. конф. "Современные методы лечения рака предстательной железы". - К., 2002. - С. 19-20. 5. Amadeo M. Anti-androgen treatment of aggressivity in men suffering from dementia // J. Geriatr. Psychiatry Neurol. - 1996. - Vol. 9. - P. 142-145. 6. Berlin F.S., Meinecke C.F. Treatment of sex offenders with antiandrogenic medication: conceptualization, review of treatment modalities, and preliminary findings // Am. J. Psychiatry. - 1981. - Vol. 138. - P. 601-711. 7. Berlin F.S. Sex offenders: A biomedical perspective and a status report on biomedical treatment. The sexual aggressor: Current perspectives on treatment. - N.Y.: Van Nostrand Reinhold, 1983. 8. Berlin F.S. Sex offender treatment and legislation // J. Am. Acad. Psychiatry Law. - 2003. - Vol. 31. - P. 510-533. 9. Bradford J.M.W. The antiandrogen and hormonal treatment of sex offenders. Handbook of sexual assault: Issues, theories, and treatment of the offender. - N.Y.: Plenum Press, 1990. - Vol. 4. - P. 297-310. 10. Bradford J.M.W., Pawlak A. Effects of cyproterone acetate on sexual arousal patterns of pedophiles // Arch. Sex. Behav. - 1993. - Vol. 22. - P. 629-641. 11. Bradford J.M.W., Kaye N.S. Pharmacological treatment of sexual offenders // Am. Acad. Psychiatry Law Newslett. - 1999. - Vol. 24. - P. 16-17. 12. Bradford J.M.W. The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behavior // Can. J. Psychiatry. - 2001. - Vol. 46. - P. 26-34. 13. Brahams D. Voluntary chemical castration of a mental patient // Lancet. - 1988. - Vol. 31. - P. 1291-1292. 14. Briken P., Berner W., Noldus J. et al. Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRHagonist leuprolide acetate // Nervenarzt. - 2000. - Vol. 71. - P. 380-385. 15. Briken P., Nika E., Berner W. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists // J. Sex Marital Ther. - 2001. - Vol. 27. - P. 45-55. 16. Briken P., Hill A., Berner W. A relapse in pedophilic sex offending and subsequent suicide attempt during luteinizing hormone-releasing hormone treatment // J. Clin. Psychiatry. - 2004. - Vol. 65. - P. 1429-1434. 17. Briken P., Welzel K., Habermann N. et al. Antiandrogenic pharmacotherapy of sexual offenders and home leave steps in the forensic psychiatric hospital Berlin // Psychiatr. Prax. - 2009. - Vol. 36. - P. 232-237. 18. Conn P.M., Crowley W.F.Jr. Gonadotropin-releasing hormone and its analogues // N. Engl. J. Med. - 1990. - Vol. 324. - P. 93-103. 19. Cooper A.J. Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia // J. Clin. Psychiatry. - 1987. - Vol. 48. - P. 368-370. 20. Cooper A.J., Sandhu S., Losztyn S. A double-blind placebo controlled trial of medroxyprogestrone acetate and cyproterone acetate with seven pedophiles // Can. J. Psychiatry. - 1992. - Vol. 37. - P. 33-39. 21. Cordier B., Thibaut F., Kuhn J.M. et al. Hormonal treatments for disorders of sexual conduct // Bull. Acad. Natl Med. - 1996. - Vol. 180. - P. 599-605. 22. Czerny J.P., Briken Р., Berner W. Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics // Eur. Psychiatry. - 2002. - Vol. 17. - P. 104-106. 23. Dickey R. The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist // Can. J. Psychiatry. - 1992. - Vol. 37. - P. 567-569. 24. Dickey R. Case report: the management of bone demineralization associated with long term treatment of multiple paraphilia with long acting LHRH agonists // J. Sex Marital Ther. - 2002. - Vol. 28. - P. 207-210. 25. Gallagher J.C., Rapuri P.B. Osteoporosis: Pathophysiology. Encyclopedia of hormones. - San Diego, CA: Academic Press, 2003. - Vol. 3. - P. 89-98. 26. Gijs L.,Gooren L. Hormonal and psychopharmacological interventions in the treatment of paraphilias: An update // J. Sex Res. - 1996. - Vol. 33. - P. 273-290. 27. Giltay E.J., Gooren L.J. Potential side effects of androgen deprivation treatment in sex offenders // J. Am. Acad. Psychiatry Law. - 2009. - Vol. 37. - P. 53-58. 28. Gooren L.J., Lips P., Gijs L. Osteoporosis and androgendepleting drugs in sex offenders // J. Forensic Sci. - 2001. - Vol. 357. - P. 1208-1209. 29. Gordon H., Grubin D. Psychiatric aspects of the assessment and treatment of sex offenders // Royal College of Psychiatrists. - 2004. - Vol. 10. - P. 73-80. 30. Gottesman H.G, Schubert D.S. Low-dose oral medroxyprogesterone acetate in the management of the paraphilias // J. Clin. Psychiatry. - 1993. - Vol. 54. - P. 182-188. 31. Grasswick L.J, Bradford J.M.W. Osteoporosis associated with the treatment of paraphilias: A clinical review of seven case reports // J. Forensic Sci. - 2003. - Vol. 48. - P. 8 4 9 - 8 5 5 . 32. Grossman L.S., Gordon C., Hall N. et al. Sexual Offender Recidivism Revisited: A Meta-Analysis of Recent Treatment Studies // J. Consult. Clin. Psychol. - 1995. - Vol. 63. - P. 806-808. 33. Grossman L.S., Martis B., Fichtner C.G. Are Sex Offenders Treatable? A Research Overview // Psychiatr. Serv. - 1999. - Vol. 50. - P. 351-359. 34. Hansen H., Lykke-Olesen L. Treatment of dangerous sexual offenders in Denmark // J. Forensic Psychiatry. - 1997. - Vol. 8. - P. 195-199. 35. Haussermann P., Goecker D., Beier K. et al. Low-dose cyproterone acetate treatment of sexual acting out in men with dementia // Int. Psychogeriatr. - 2003. - Vol. 15. - P. 181-186. 36. Hebebrand K., Hebebrand J., Remschmidt H. Pharmacological agents for treatment of paraphilias and hypersexual disorders // Fortschr. Neurol. Psychiatr. - 2002. - Vol. 70, N 9. - P. 4 6 2 - 47 5 . 37. Higano C.S. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity // Urology. - 2003. - Vol. 61. - P. 32-38. 38. Hill A., Briken P., Kraus C. et al. Differential pharmacological treatment of paraphilias and sex offenders // Int. J. Offender Ther. Comp. Criminol. - 2003. - Vol. 47. - P. 407-421. 39. Hoogeveen G.H, Van Der Veer E. Side effects of pharmacotherapy on bone with long-acting gonadorelin agonist triptorelin for paraphilia // J. Sex Med. - 2008. - Vol. 5. - P. 626-630. 40. Kafka M.P. Therapy for Sexual Impulsivity: The Paraphilias and Paraphilia-Related Disorders // Psychiatr. Times. - 1996. - Vol. 13. - P. 6-16. 41. Kravitz H.M., Haywood T. W., Kelly J. et al. Medroxyprogesterone and paraphiles: do testosterone levels matter? // Bull. Am. Acad. Psychiatry Law. - 1996. - Vol. 24. - P. 73-83. 42. Krueger R.B., Kaplan M.S. Depot-leuprolide acetate for treatment of paraphilias: a report of twelve cases // Arch. Sex. Behav. - 2001. - Vol. 30. - P. 409-422. 43. Krueger R.B., Kaplan M.S. Behavioral and psychopharmacological treatment of the paraphilic and hypersexual disorders // J. Psychiatr. Pract. - 2002. - Vol. 8. - P. 21-32. 44. Krueger R.B., Hembree W., Hill M. Prescription of medroxyprogesterone acetate to a patient with pedophilia, resulting in Cushing syndrome and adrenal insufficiency // Sex. Abuse. - 2006. - Vol. 18. - P. 227-228. 45. Kumar R.J., Barqawi A., Crawford E.D. Preventing and treating the complications of hormone therapy // Curr. Urol. Rep. - 2005. - Vol. 6. - P. 217-223. 46. Laron Z., Kauli R. Experience with the cyproterone acetate in the treatment of precocious puberty // J. Pediatr. Endocrinol. Metab. - 2000. - Vol. 13. - P. 805-810. 47. Levitsky A.M., Owens, N.J. Pharmacologic treatment of hypersexuality and paraphilias in nursing home residents // J. Am. Geriatr. Soc. - 1999. - Vol. 47. - P. 231-234. 48. Light S.A., Holroyd S. The use of medroxyprogesterone acetate for the treatment of sexually inappropriate behavior in patients with dementia // J. Psychiatry Neurosci. - 2006. - Vol. 31. - P. 132-134. 49. Maletzky B.M. Treating the sexual offender. - Newbury Park, CA: Sage, 1991. - Vol. 7. - P. 16-25. 50. Meyer W.J., Cole C.M., Emory E. Depo provera treatment of sex offending behavior: an evaluation of outcome // Bull. Am. Acad. Psychiatry Law. - 1992a. - Vol. 20. - P. 249-259. 51. Neumann F. Pharmacological basis for clinical use of antiandrogens // J. Steroid Biochem. - 1983. - Vol. 19. - P. 3 9 1- 3 4 0 . 52. Neumann F., Kalmus J. Cyproterone acetate in the treatment of sexual disorders: pharmacological base and clinical experience // Exp. Clin. Endocrinol. - 1991. - Vol. 98. - P. 71-80. 53. Neumann R. Pharmacology and potential use of cyproterone acetate // Horm. Metab. Res. - 1997. - Vol. 9. - P. 1-13. 54. O’Connell M.B., Seaton T.L. Osteoporosis and osteomalacia // Pharmacotherapy: Apathophysiologic approach. - N.Y.: McGraw-Hill, 2005. - Vol. 6. - P. 1645-1669. 55. Ott B.R. Leuprolide treatment of sexual aggression in a patient with dementia and the Kluver-Bucy syndrome // Clin. Neuropharmacol. - 1995. - Vol. 18. - P. 443-447. 56. Pavone-Macaluso M., de Voogt H.J., Viggiano G. et al. Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group // J. Urol. - 1986. - Vol. 136. - P. 6 24 - 6 3 1. 57. Prentky R.A. Arousal reduction in sexual offenders: A review of antiandrogen interventions // Sex. Abuse: A Journal of Research and Treatment. - 1997. - Vol. 9. - P. 335-349. 58. Reilly D.R., Delva N.J., Hudson R.W. Protocols for the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia // Can. J. Psychiatry. - 2000. - Vol. 45. - P. 559-563. 59. Rich S.S., Ovsiew F. Leuprolide acetate for exhibitionism in Huntington’s disease // Mov. Disord. - 1994. - Vol. 9. - P. 353-357. 60. Richer M., Crismon M.L. Pharmacotherapy of sexual offenders // Ann. Pharmacother. - 1993. - Vol. 27. - P. 316-320. 61. Rцsler A., Witztum E. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone // N. Engl. J. Med. - 1998. - Vol. 338. - P. 416-422. 62. Rцsler A., Witztum E. Pharmacotherapy of paraphilias in the next millennium // Behav. Sci. Law. - 2000. - Vol. 18. - P. 4 3 - 5 6 . 63. Rousseau L., Couture M., Dupont A. et al. Effect of combined androgen blockade with an LHRH agonist and fl utamide in one severe case of male exhibitionism // Can. J. Psychiatry. - 1990. - Vol. 35. - P. 338-341. 64. Saleh F.M., Guidry L.L. Psychosocial and biological treatment considerations for the paraphilic and nonparaphilic sex offender // J. Am. Acad. Psychiatry Law. - 2003. - Vol. 31. - P. 4 8 6 - 4 9 3 . 65. Saleh F.M., Berlin F.S. Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders // J. Child Sex. Abus. - 2003. - Vol. 12. - P. 2 3 3 - 2 5 3 . 66. Saleh F.M., Niel T., Fishman M.J. Treatment of paraphilia in young adults with leuprolide acetate: A preliminary case report series // J. Forensic Sci. - 2004. - Vol. 49. - P. 1-6. 67. Saleh F.M. Serotonin reuptake inhibitors and the paraphilias // Am. Acad. Psychiatry Law Newslett. - 2004. - Vol. 23. - P. 12 -13 . 68. Saleh F.M. A hypersexual paraphilic patient treated with leuprolide acetate: a single case report // J. Sex Marital Ther. - 2005. - Vol. 31. - P. 433-444. 69. Schneider H.P. Androgens and antiandrogens // Ann. N.Y. Acad. Sci. - 2003. - Vol. 997. - P. 292-306. 70. Schober J.M., Byrne P., Kuhn P.J. Leuprolide acetate is a familiar drug that may modify sex-offender behaviour: the urologist’s role // BJU Int. - 2006. - Vol. 97. - P. 684-686. 71. Schober J.M., Kuhn P.J., Kovacs P.G. et al. Leuprolide acetate suppresses pedophilic urges and arousability // Arch. Sex. Behav. - 2005. - Vol. 34. - P. 691-705. 72. Series H., Dйgano P. Advances in Psychiatric Treatment // J. Forensic Psychiatry. - 2005. - Vol. 11. - P. 424-431. 73. Smith M.R. Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma // Cancer Suppl. - 2003. - Vol. 97. - P. 789-795. 74. Stewart J.T. Optimizing antilibidinal treatment with medroxyprogesterone acetate // J. Am. Geriatr. Soc. - 2005. - Vol. 53 - P. 3 5 9 - 3 6 0 . 75. Thibaut F., Cordier B., Kuhn J.M. Effect of a long-acting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia // Acta Psychiatr. Scand. - 1993. - Vol. 87. - P. 445-450. 76. Thibaut F., Kuhn J.M., Cordier B. et al. Hormone treatment of sex offenses // J. Am. Geriatr. Soc. - 1998. - Vol. 24. - P. 132-137. 77. Volavka J. Neurobiology of violence. - Washington, DC: American Psychiatric Press, 1995. 78. Walker P., Meyer W.J. Medroxyprogesterone acetate for paraphiliac sex offenders. - N.Y.: SP Medical and Scientific Books, 1981. - Vol. 32. - P. 103-110. 79. Weiner M.F., Denke M., Williams K. et al. Intramuscular medroxyprogesterone acetate for sexual aggression in elderly men // Lancet. - 1992. - Vol. 339. - P. 1121-1122. 80. Wilke D.R., Parker C., Andonowski A. et al. Testosterone and erectile function recovery after radiotherapy and long-term androgen deprivation with luteinizing hormone-releasing hormone agonists // BJU Int. - 2006. - Vol. 97. - P. 963-968.

Метрики статей

Загрузка метрик ...

Metrics powered by PLOS ALM